Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549996 | SCV000623075 | benign | Gorlin syndrome | 2025-01-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001579391 | SCV002013236 | likely benign | not provided | 2020-11-24 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001579391 | SCV001807060 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001579391 | SCV001965038 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004553166 | SCV004728449 | likely benign | PTCH2-related disorder | 2019-05-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |